• Women's Health Nursing
• /
• v.3 no.2
• /
• pp.268-281
• /
• 1997

This study was done for the purpose of analysing the relationship between menopausal syndrome and depression in the pre and post menopausal women's group. Data were collected by a questionnaire from November, 1995 to December, 1996. The subject were 244 midlife women(94 subjects were in pre-menopausal period, 150 subject were in post-menopausal period). The instruments used for this study were the menopausal syndrome scale by Neugarton and depression scale by Zung. Data were analyzed with the SPSS/PC using frequency, t-test, and Pearson correlation coefficients. The results of this study were as follows ; 1. The most serious menopausal symptom in the midlife women was 'back pain and joint pain'. 2. The item of 'Hot flush'(t=-2.78, p<0.01), 'sweating'(t=-2.31, p<0.05) and 'nervousness'(t=-2.13, p<0.05) as menopausal syndromes were statistically significant in the two groups ; Post menopausal group were higher then premenopausal group. 3. Postmenopausal group were a little higher then premenopausal group as depression level. It was none statistically significant in the two groups. 4. The relationship between menopausal syndromes and the level of depression was statistically significant in the group of post-menopausal group(r=0.2083, p<0.01).

• Korean Journal of Psychosomatic Medicine
• /
• v.22 no.2
• /
• pp.138-142
• /
• 2014

Burning mouth syndrome is characterized by intra-oral burning sensation without any organic abnormalities. This syndrome is associated with various etiological factors such as neuropathy, malnutrition, menopause and depression. Several medications have been tried for the treatment. Those are analgesics, hormones, anticonvulsants and antidepressants. However, optimal effective pharmacologic treatment remains still unknown. The purpose of this case study is to report the clinical effectiveness of gabapentin in the treatment of burning mouth syndrome in postmenopausal women with comorbid depression. We report two menopausal women. Antidepressants were effective for improving depressive symptoms, but it had no effects on intra-oral burning sensation. Gabapentin reduced intra-oral burning sensation effectively for all two patients. One patient reported 55% reduction(a decrease from 9 to 4 on VAS), the other patient reported 35% reduction(from 8 to 5) of the intra-oral burning sensation during 16 weeks. The minimal effective daily dose of gabapentin was 300mg. This study suggests that gabapentin might be a useful, effective therapeutic option for treating burning mouth syndrome in postmenopausal women with comorbid depression. Further prospective clinical studies are needed to investigate the effectiveness of gabapentin in patients with burning mouth syndrome.